These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22057290)

  • 41. CYLD negatively regulates nontypeable Haemophilus influenzae-induced IL-8 expression via phosphatase MKP-1-dependent inhibition of ERK.
    Wang WY; Komatsu K; Huang Y; Wu J; Zhang W; Lee JY; Miyata M; Xu H; Li JD
    PLoS One; 2014; 9(11):e112516. PubMed ID: 25389768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Essential role of sequestosome 1/p62 in regulating accumulation of Lys63-ubiquitinated proteins.
    Wooten MW; Geetha T; Babu JR; Seibenhener ML; Peng J; Cox N; Diaz-Meco MT; Moscat J
    J Biol Chem; 2008 Mar; 283(11):6783-9. PubMed ID: 18174161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct activation of protein kinases by unanchored polyubiquitin chains.
    Xia ZP; Sun L; Chen X; Pineda G; Jiang X; Adhikari A; Zeng W; Chen ZJ
    Nature; 2009 Sep; 461(7260):114-9. PubMed ID: 19675569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Truncation of the deubiquitinating domain of CYLD in myelomonocytic cells attenuates inflammatory responses.
    Tsagaratou A; Kontoyiannis DL; Mosialos G
    PLoS One; 2011 Jan; 6(1):e16397. PubMed ID: 21283724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The tumour suppressor CYLD regulates the p53 DNA damage response.
    Fernández-Majada V; Welz PS; Ermolaeva MA; Schell M; Adam A; Dietlein F; Komander D; Büttner R; Thomas RK; Schumacher B; Pasparakis M
    Nat Commun; 2016 Aug; 7():12508. PubMed ID: 27561390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-1beta-induced IKK/NF-kappaB and JNK/AP-1 activation.
    Fan Y; Yu Y; Shi Y; Sun W; Xie M; Ge N; Mao R; Chang A; Xu G; Schneider MD; Zhang H; Fu S; Qin J; Yang J
    J Biol Chem; 2010 Feb; 285(8):5347-60. PubMed ID: 20038579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module.
    Komander D; Lord CJ; Scheel H; Swift S; Hofmann K; Ashworth A; Barford D
    Mol Cell; 2008 Feb; 29(4):451-64. PubMed ID: 18313383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CYLD: a multifunctional deubiquitinase.
    Glittenberg M; Ligoxygakis P
    Fly (Austin); 2007; 1(6):330-2. PubMed ID: 18820455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Itch WW Domains Inhibit Its E3 Ubiquitin Ligase Activity by Blocking E2-E3 Ligase Trans-thiolation.
    Riling C; Kamadurai H; Kumar S; O'Leary CE; Wu KP; Manion EE; Ying M; Schulman BA; Oliver PM
    J Biol Chem; 2015 Sep; 290(39):23875-87. PubMed ID: 26245901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6.
    Jung SM; Lee JH; Park J; Oh YS; Lee SK; Park JS; Lee YS; Kim JH; Lee JY; Bae YS; Koo SH; Kim SJ; Park SH
    Nat Commun; 2013; 4():2562. PubMed ID: 24096742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune dysregulation in SHARPIN-deficient mice is dependent on CYLD-mediated cell death.
    Ang RL; Chan M; Legarda D; Sundberg JP; Sun SC; Gillespie VL; Chun N; Heeger PS; Xiong H; Lira SA; Ting AT
    Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34887354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cylindromatosis mediates neuronal cell death in vitro and in vivo.
    Ganjam GK; Terpolilli NA; Diemert S; Eisenbach I; Hoffmann L; Reuther C; Herden C; Roth J; Plesnila N; Culmsee C
    Cell Death Differ; 2018 Aug; 25(8):1394-1407. PubMed ID: 29352268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor suppressor CYLD acts as a negative regulator for non-typeable Haemophilus influenza-induced inflammation in the middle ear and lung of mice.
    Lim JH; Jono H; Koga T; Woo CH; Ishinaga H; Bourne P; Xu H; Ha UH; Xu H; Li JD
    PLoS One; 2007 Oct; 2(10):e1032. PubMed ID: 17925880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells.
    Jin W; Reiley WR; Lee AJ; Wright A; Wu X; Zhang M; Sun SC
    J Biol Chem; 2007 May; 282(21):15884-93. PubMed ID: 17392286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased A20-E3 ubiquitin ligase interactions in bid-deficient glia attenuate TLR3- and TLR4-induced inflammation.
    Kinsella S; Fichtner M; Watters O; König HG; Prehn JHM
    J Neuroinflammation; 2018 May; 15(1):130. PubMed ID: 29720226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected].
    Ho KC; Zhou Z; She YM; Chun A; Cyr TD; Yang X
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4870-5. PubMed ID: 21383157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.
    Jin W; Chang M; Paul EM; Babu G; Lee AJ; Reiley W; Wright A; Zhang M; You J; Sun SC
    J Clin Invest; 2008 May; 118(5):1858-66. PubMed ID: 18382763
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The E3 ubiquitin ligase Itch and Yap1 have antagonistic roles in the regulation of ASPP2 protein stability.
    Gao K; An J; Zhang Y; Jin X; Ma J; Peng J; Tang Y; Yu L; Zhang P; Wang C
    FEBS Lett; 2015 Jan; 589(1):94-101. PubMed ID: 25436413
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth.
    Feng X; Jia Y; Zhang Y; Ma F; Zhu Y; Hong X; Zhou Q; He R; Zhang H; Jin J; Piao D; Huang H; Li Q; Qiu X; Zhang Z
    Autophagy; 2019 Jul; 15(7):1130-1149. PubMed ID: 30686098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. USP19 Inhibits TNF-α- and IL-1β-Triggered NF-κB Activation by Deubiquitinating TAK1.
    Lei CQ; Wu X; Zhong X; Jiang L; Zhong B; Shu HB
    J Immunol; 2019 Jul; 203(1):259-268. PubMed ID: 31127032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.